Article Details

New Novartis data further support benefits of Kesimpta® in relapsing MS following switch ...

Retrieved on: 2025-09-24 12:46:13

Tags for this article:

Click the tags to see associated articles and topics

New Novartis data further support benefits of Kesimpta® in relapsing MS following switch .... View article details on hiswai:

Excerpt

Data on file. ###. Novartis Media Relations. E-mail: media.relations@novartis.com.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo